No.15, Lane 88 Wuwei Road, Putuo District, Shanghai
Tel: (+86) 021-50498986
Luo Chunyi（羅春憶）, aged 51, is our executive Director and chief executive officer. Mr. Luo has extensive experience in corporate management and banking. Prior to joining the Group, he had served in Ping An Bank (formerly known as Shenzhen Development Bank) for 23 years since 1995. He held various senior positions in Ping An Bank, including the general manager of Haikou Haidian sub-branch and the assistant general manager of Haikou branch. He also worked as a manager in China Construction Bank from 1989 to 1995 before joining Ping An Bank. Mr. Luo graduated from the school of law of Hainan University (海南大學) in 2001. Mr. Luo obtained the qualification of economist (economic professional) in 1999 awarded by the Human Resource Office of Hainan province.
YU Yue (余悅), aged 38 , is our government affairs director. Ms. Yu joined our Group in October 2013 and was appointed as government affairs director, responsible for the Group’s government affairs and government relation management. Ms. Yu graduated from Dongbei University of Finance and Economics with a bachelor’s degree in management in September 2004, and with a master’s degree in enterprise management in January 2007.
XUE Yi (薛毅), aged 44, is our chief financial officer. Mr. Xue joined the Group in January 2002 and served as the manager of the audit department of Pioneer Pharma between January 2002 and January 2003, and was appointed as the manager of the finance department of Pioneer Pharma since February 2003. Mr. Xue was appointed as the Company’s deputy financial officer since February 2015, responsible for assisting chief financial officer with finance and accounting management, and was appointed as chief financial officer in December 2016. Mr. Xue is also the executive director of the Company’s wholly-owned subsidiary Naqu Area Pioneer Pharma Co., Ltd. Mr. Xue has over 21 years of experience in the accounting and auditing field. Prior to joining the Group, Mr. Xue worked at Sichuan Dazhou Foods Company (四川省達州市食品公司). Mr. Xue obtained a bachelor’s degree in accounting from Southwestern University of Finance and Economics in June 1997, and obtained the qualification of Medium Level Accountant in August 2000.
YANG Xiuyan (楊秀顏), aged 57, is our general manager of Polichem business unit. Ms. Yang joined our Group in December 1998 and worked as the manager for Shandong and Northern China area between 1998 and 2012. She was appointed as our deputy general manager and sales director in January 2013 and was responsible for the sales and marketing of our Group, in particular in the Northern Yangtze River area. In September 2014, Ms. Yang was promoted as a general manager of AW (Alfa Wassermann) Business Unit, and is responsible for the promotion and sales of AW’s products of our Group. In November 2015, Ms. Yang was appointed as the general manager of Polichem Business Unit, and is responsible for the promotion and sales of Polichem’s products of the Group. She has nearly 20 years working experience in the pharmaceutical industry. Prior to joining our Group, Ms. Yang worked at Boli People’s Hospital of Heilongjiang Province (黑龍江省勃利人民醫院). Ms. Yang was awarded with a bachelor’s degree in clinical medicine by the Binzhou Medical University (濱州醫學院) in July 1986.
Steven Yang is the General Manager of AW Department , who is aged 32. Mr Yang joined Pioneer-Pharma in 2016. He served as Product Manager,Marketing Manager during 2016-2019. Mr Yang was appointed as the General Manager of AW Department in October，2019. He is in charge of both marketing and sales of series of products of ALFASIGMA and NovaBay. Mr Yang was responsible for sales of CVM in Novartis and AstraZeneca. Mr Yang was majored in Pharmaceutical Chemistry with combined training mode and graduated from Shanghai State Institute Of Pharmaceutical Industry (which is renamed as China State Institute Of Pharmaceutical Industry )with a master’s degree in July，2013.
QU Lei (瞿蕾), aged 40, is our general manager of Pain Management and Digestive Products Business Unit. Ms. Qu joined our Group in March 2010, and worked as a senior product manager from 2010 to September 2014. She was appointed as a manager of the marketing department of the Pain Management and Digestive Products business unit of the Group in September 2014, was appointed as a manager of the Managerial department and Human Resources department in September 2015, and was appointed as a director of the Administration Affairs and Human Resources of the Group in December 2016, responsible for work related to administrative affairs and human resources. In September 2018, she was appointed as general manager of Pain Management and Digestive Products Business Unit and is responsible for the promotion and sales of Difene and digestive products of our Group. Ms. Qu has over 16 years of experience in the pharmaceutical industry. Prior to joining the Group, Ms. Qu worked at the Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai Medical Emergency Center, MSD (Hangzhou) Pharmaceutical Company Limited and Shanghai Boehringer Ingelheim Pharmaceutical Company Limited.
WANG Rongrong (王榮榮), aged 41, is our general manager of Alcon business unit and national director of commerce department. Ms. Wang joined our Group in July 2004, and worked as a manager of commerce department from September 2006 to August 2014. In September 2014, Ms. Wang was promoted as our national director of commerce department, mainly responsible for bidding, pricing, receivables management and channel management and other business related work. Ms. Wang was appointed as our general manager of Alcon business unit in January 2016, mainly responsible for co-promotion and channel management of Alcon’s products of the Group. Ms. Wang has more than 19 years of working experience in pharmaceutical industry. Prior to joining the Group, Ms. Wang worked in Hainan Sanye Pharmaceutical Group (海南三葉醫藥集團). Ms. Wang received a bachelor’s degree in biological engineering in June 2000, and a licensed pharmacist qualification certificate in 2005.
HUANG Wenfei (黃文斐), aged 50, is our general manager of ophthalmology business unit. Ms. Huang joined our Group in 1998 and worked as a manager of our commerce department between 1998 and 2004 and a sales director in 2004. She was appointed as our deputy general manager in October 2004 and a director of Pioneer Pharma in April 2011, responsible for various aspects of our business, including human resources, administration, product registration, purchase, logistics, product quality, commerce and government affairs. In September 2014, Ms. Huang was promoted as a general manager of our ophthalmology business unit, responsible for the promotion and sales of all the ophthalmic medical devices products of our Group. Ms. Huang has nearly 24 years of working experience in the pharmaceutical industry. Prior to joining our Group, she worked at Shanghai Xudong Haipu Pharmaceutical Co., Ltd. (上海旭東海普藥 業有限公司) and Shanghai Eighteenth Pharmaceutical (上海第十八製藥廠). Ms. Huang obtained an executive master’s degree in business administration by Tongji University (同濟大學) in March 2009.
JIANG Li (江俐), aged 45, is general manager of Shanghai Pioneer Ruici Medical Facilities Company Limited. Ms. Jiang joined our Group in January 2013 and served as an odontology product manager. In December 2016, she was appointed as the general manager of Shanghai Pioneer Ruici Medical Facilities Company Limited., and is responsible for the promotion and sales of odontology products. Ms. Jiang has over 21 years of experience in the medical device industry. Prior to joining the Group, Ms. Jiang worked at Shanghai Tesco Dental Trading Co., Ltd., Singapore Kavo Dental Asia Pacific Private Limited, SHOFU Dental Equipment Trade (Shanghai) Co., Ltd. and Beijing Bien Air Medical Technologies Co., Ltd.
LIU Xuefeng (劉雪峰), aged 44, is our business development director. Mr. Liu joined our Group in September 2008 and was appointed as our business development director in April 2012, mainly responsible for sourcing new products and exploring business opportunities. Mr. Liu has over 14 years working experience in the pharmaceutical industry. Prior to joining our Group, Mr. Liu was a medical representative at AstraZeneca (Wuxi) Trading Co. Ltd. (阿斯利康（無錫）貿易 有限公司) between January 2008 and August 2008, responsible for promoting medical and pharmaceutical products knowledge to customers. Mr. Liu worked as an assistant secretary-general and head of international council at Chinese Society of Biochemistry and Molecular Biology (中國生物化學與分子生物學會) starting in July 2005. Between August 1999 and September 2002, he worked at Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (杭州中美華東製藥有 限公司). Mr. Liu was awarded with a bachelor’s degree in biopharming by China Pharmaceutical University (中國醫科大學) in July 1999 and a master’s degree in microbiology and biochemical pharmacy by Shanghai Institute of Pharmaceutical Industry (上海醫藥工業研究院) in July 2005.